A Novel Nomogram Based on a Competing Risk Model Predicting Cardiovascular Death Risk in Patients With Chronic Kidney

Ning Li1, Jingjing Zhang1, Yumeng Xu1

  • 1Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.

Insights

This study developed a new nomogram to predict cardiovascular death risk in chronic kidney disease (CKD) patients. The tool integrates age, homocysteine, potassium, CKD stage, and anemia for better clinical risk assessment.

Area of Science:

  • Nephrology
  • Cardiology
  • Biostatistics

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in patients with chronic kidney disease (CKD), often surpassing the risk of renal failure.
  • Accurate prediction of CVD risk is crucial for timely intervention and improved outcomes in CKD patients.

Purpose of the Study:

  • To develop and validate a novel nomogram for predicting the risk of cardiovascular death in patients with CKD.
  • To identify key predictors of cardiovascular mortality in this population.

Main Methods:

  • A cohort of 1656 CKD patients from the NHANES 2003-2006 survey was analyzed.
  • A nomogram was constructed using 2005-2006 data and validated with 2003-2004 data.
  • Univariate analysis and backward-stepwise regression identified predictors; performance was assessed using AUC and calibration curves.

Main Results:

  • The nomogram includes age, homocysteine, potassium levels, CKD stage, and anemia.
  • Internal validation showed high discrimination (5-year AUC 0.79, 7-year 0.81, 9-year 0.81).
  • External validation confirmed good performance (5-year AUC 0.76, 7-year 0.73, 9-year 0.73).

Conclusions:

  • A novel nomogram integrating key clinical factors accurately predicts cardiovascular death risk in CKD patients.
  • This tool offers potential for improved clinical decision-making and patient management.
  • The nomogram effectively differentiates high-risk from low-risk individuals.
Abstract

Related Concept Videos

Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
66
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
91
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
85
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
116
Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
216
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
66